市場調查報告書
商品編碼
1471244
增溶添加劑市場:依產品類型、應用分類 - 2024-2030 年全球預測Solubility Enhancement Excipients Market by Product (Particle Size Reduction, Solid Dispersion), Type (Lipid, Polymer, Surfactant), Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
增溶劑市場規模預估2023年為36.3億美元,預估2024年將達38.2億美元,2030年將達53.3億美元,複合年成長率預估為5.62%。
增溶添加劑是一類特定的藥物成分,主要用於藥品製造過程中,以增加難溶化合物的溶解度。它透過促進藥物在體內溶出,在提高生物有效性和增強治療效果方面發揮重要作用。由於慢性病的增加以及藥物發現和開發,製藥業對增強溶解度添加劑的需求正在加速成長。然而,原料成本的波動和嚴格的法規可能會對最終用途領域中增溶劑的使用產生負面影響。此外,奈米技術的普及、生物基賦形劑的加入以及多功能賦形劑的開發預計將為增溶添加劑領域的發展提供巨大的潛力。
主要市場統計 | |
---|---|
基準年[2023] | 36.3億美元 |
預計年份 [2024] | 38.2億美元 |
預測年份 [2030] | 53.3億美元 |
複合年成長率(%) | 5.62% |
消費者喜歡減小粒徑,因為它可以提高產品的載藥效率
粒徑減小 (PSR) 涉及減小藥物或賦形劑的粒徑以增加表面積和溶解度。此製程具有相當大的優勢,包括提高載藥效率、優異的均勻性和提高溶離度,特別是對於水溶性差的藥物。固體分散體是一種將疏水性藥物有效封裝在水溶性載體基質中的策略。當配製經減小粒徑無法達到所需溶解度的藥物時,優選固態分散體。儘管粒徑減小相對簡單且成本效益高,但並非對所有類型的藥物都有效,尤其是水溶性極低的藥物。固體分散體可處理此類難以溶解的藥物。它更昂貴,因為它需要更複雜的工藝和先進的技術。
類型:廣泛使用界面活性劑作為增溶劑添加劑來開發基於界面活性劑的藥物遞送系統
由於脂質無毒性、生物分解性以及形成各種包合物結構(例如膠束和脂質體)的能力,脂質通常被用作溶解度增強添加劑。由於聚合物的多功能性和相對較低的生產成本,聚合物對於提高溶解度至關重要。界面活性劑無所不在,因為它們能夠穩定水-油界面並降低表面張力,這對於增加溶解度非常重要。脂質因其安全性和生物分解性而受到重視,表面活性劑因其穩定特性而受到重視,聚合物因其經濟性和適應性而受到重視。
應用:增溶劑在製藥領域的重要角色是促進產品卓越。
醫療保健是醫療系統的第一線,快速反應至關重要。增加溶解度的賦形劑可加速藥物在體內的吸收,快速緩解患者的症狀。在製藥領域,需要增強溶解度的添加劑來增強口服藥物的吸收,並優先考慮藥物在各種條件下的穩定性、安全性和有效性。醫院尋求更快的吸收以立即緩解患者的痛苦,而製藥部門則專注於藥物的穩定性、安全性和有效性。
區域洞察
在美洲,由於製藥工業的成熟、藥物配方的創新以及藥物製造技術的進步,增溶添加劑市場正在發展。在亞太地區,由於慢性病的增加、研發活動的活性化以及學名藥產量的增加,對增溶劑的需求正在顯著成長。由於強大的研發基礎、新型口服輔料的持續開發以及不斷擴大的醫療基礎設施,歐洲、中東和非洲 (EMEA) 對增強溶解度的輔料表現出很高的需求。此外,增溶添加劑生產的技術進步以及改善其性能的持續研究預計將擴大增溶添加劑在全球最終用途領域的使用。
FPNV定位矩陣
FPNV定位矩陣對於評估增溶劑市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對增溶添加劑市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,以獲得市場競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.增溶劑市場規模及預測是多少?
2.在增溶添加劑市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.增溶劑市場的技術趨勢和法規結構是什麼?
4.增溶添加劑市場主要供應商的市場佔有率為何?
5. 進入增溶添加劑市場的合適型態和策略手段是什麼?
[190 Pages Report] The Solubility Enhancement Excipients Market size was estimated at USD 3.63 billion in 2023 and expected to reach USD 3.82 billion in 2024, at a CAGR 5.62% to reach USD 5.33 billion by 2030.
Solubility enhancement excipients are a specific category of pharmaceutical ingredients used primarily in the drug manufacturing process to increase the solubility of poorly soluble drug compounds. They play a critical role in bioavailability enhancement, facilitating the dissolution of drugs into the body and thus increasing their therapeutic effectiveness. The rise in chronic diseases and increase in drug discovery and development are accelerating the need for solubility enhancement excipients from the pharmaceutical industries. However, volatility in raw material cost and stringent regulations may adversely impact the use of solubility enhancement excipients by the end-use sectors. Moreover, the proliferation of nanotechnology, the incorporation of bio-based excipients, and the development of multifunctional excipients are expected to create immense potential for the growth of solubility enhancement excipients worldwide.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.63 billion |
Estimated Year [2024] | USD 3.82 billion |
Forecast Year [2030] | USD 5.33 billion |
CAGR (%) | 5.62% |
Product: Consumer preference for particle size reduction as it provides improved drug loading efficiency
Particle size reduction (PSR) involves reducing the particle size of drug substances or excipients to enhance the surface area and solubility. This process offers considerable advantages, such as improved drug loading efficiency, excellent homogeneity, and improved dissolution rate of drugs, particularly for drugs with poor water solubility. Solid dispersion is the strategy for efficiently encapsulating a hydrophobic drug within a water-soluble carrier matrix. It is preferred when dealing with the formulation of drugs that cannot achieve desired solubility levels through particle size reduction. Particle size reduction is comparatively easier and cost-effective, but it is not effective for all types of drugs, especially those with extremely poor water solubility. Solid dispersion handles tough-to-solubilize such medicines. It needs more complex steps and sophisticated technologies, making it more expensive.
Type: Extensive utilization of surfactants as solubility enhancement excipients to develop surfactant-based drug delivery systems
Lipids are often employed as solubility enhancement excipients due to their no toxicity, biodegradability, and capacity to form various inclusion structures like micelles and liposomes. Polymers are vital in solubility enhancement due to their versatility and relatively inexpensive production costs. Surfactants are ubiquitous due to their capacity to stabilize water-oil interfaces and reduce surface tension, which is critical in enhancing solubility. Lipids are appreciated for their safety and biodegradability, surfactants for their stabilizing properties, and polymers for their affordability and adaptability.
Application: Significant role of solubility enhancement excipients in the pharmaceutical field to drive product excellence
Hospitals are the frontline of the healthcare system, where immediate attention is paramount. A solubility enhancement excipient enables faster absorption of the drug into the body, providing quicker relief to the patient. The pharmaceutical sector requires solubility enhancement excipients to increase the absorption of orally taken drugs and prioritize drug stability, safety, and efficacy in different conditions. Hospitals demand faster absorption for immediate patient relief, while the pharmaceutical sector focuses on drug stability, safety, and effectiveness.
Regional Insights
The solubility enhancement excipients market is evolving in the Americas owing to the well-established pharmaceutical industries, innovations in drug formulation, and technological advancements in drug manufacturing. The Asia Pacific is witnessing significant demand for solubility enhancement excipients due to the increasing prevalence of chronic diseases, the surge in research and development activities, and high generic drug production. Europe, Middle East, and Africa (EMEA) represent high demand for solubility enhancement excipients with strong research and development foundations, ongoing development of novel excipients used in oral administration, and expanding healthcare infrastructure. Besides, technological advancements in the manufacturing of solubility enhancement excipients and ongoing research to improve their properties are anticipated to expand the use of solubility enhancement excipients across the end-use sectors globally.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Solubility Enhancement Excipients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Solubility Enhancement Excipients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Solubility Enhancement Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Air Liquide S.A., Ashland Global Holdings Inc., BASF SE, Cargill, Incorporated, Clariant International Ltd., Croda International PLC, DuPont de Nemours Inc., Evonik Industries AG, FMC Corporation, FREUND Corporation, Gattefosse, IMCD Group, JRS Pharma GmbH & Co. KG, Kerry Group PLC, Lubrizol Corporation, Merck KGaA, Nippon Soda Co. Ltd., Pharma Excipients International AG, Roquette Freres SA, Shin-Etsu Chemical Co., Ltd., Solvay SA, SPI Pharma Inc., The DOW Chemical Company, and Wacker Chemie AG.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Solubility Enhancement Excipients Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Solubility Enhancement Excipients Market?
3. What are the technology trends and regulatory frameworks in the Solubility Enhancement Excipients Market?
4. What is the market share of the leading vendors in the Solubility Enhancement Excipients Market?
5. Which modes and strategic moves are suitable for entering the Solubility Enhancement Excipients Market?